JP2015523346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523346A5 JP2015523346A5 JP2015516261A JP2015516261A JP2015523346A5 JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5 JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- neutropenia
- retinoid agonist
- pharmaceutical composition
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656815P | 2012-06-07 | 2012-06-07 | |
| US61/656,815 | 2012-06-07 | ||
| PCT/US2013/044828 WO2013185105A1 (en) | 2012-06-07 | 2013-06-07 | Methods for treating neutropenia using retinoid agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523346A JP2015523346A (ja) | 2015-08-13 |
| JP2015523346A5 true JP2015523346A5 (enExample) | 2016-06-16 |
| JP6295249B2 JP6295249B2 (ja) | 2018-03-14 |
Family
ID=49712715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516261A Expired - Fee Related JP6295249B2 (ja) | 2012-06-07 | 2013-06-07 | レチノイドアゴニストを用いた好中球減少症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11116738B2 (enExample) |
| EP (1) | EP2858636B1 (enExample) |
| JP (1) | JP6295249B2 (enExample) |
| KR (1) | KR102083046B1 (enExample) |
| CN (1) | CN104519879B (enExample) |
| AU (1) | AU2013270674B2 (enExample) |
| BR (1) | BR112014030279A2 (enExample) |
| CA (1) | CA2874850A1 (enExample) |
| ES (1) | ES2691493T3 (enExample) |
| MX (1) | MX365321B (enExample) |
| NZ (1) | NZ702415A (enExample) |
| RU (1) | RU2650962C2 (enExample) |
| WO (1) | WO2013185105A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2858636B1 (en) | 2012-06-07 | 2018-09-05 | Childrens Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| EP2969031A4 (en) | 2013-03-15 | 2017-03-08 | Avisenna Cosmetics LLC | Topical compositions for reducing aging effects |
| MX2016010699A (es) * | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| EP3277272B1 (en) * | 2015-03-31 | 2021-08-04 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-agonists |
| KR20240157122A (ko) | 2016-04-08 | 2024-10-31 | 사이로스 파마수티컬스, 인크. | Aml 및 mds 치료용 rara 효능제 |
| TW201823471A (zh) * | 2016-10-06 | 2018-07-01 | 美商錫羅斯製藥公司 | 以視黃酸受體-α促效劑及抗CD38抗體治療病患之方法 |
| US20210123021A1 (en) * | 2018-01-26 | 2021-04-29 | Agency For Science, Technology And Research | Neutrophil subtypes |
| CN113969261B (zh) * | 2020-07-06 | 2024-04-09 | 苏州市立医院(北区) | 三步法快速测定中性粒细胞趋化的方法 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| FI131561B1 (en) * | 2023-12-28 | 2025-06-30 | Faron Pharmaceuticals Oy | CLEVER-1 INHIBITOR TO PROMOTE HEMATOLOGICAL RECOVERY WHEN USING CHEMOTHERAPY |
| WO2025250787A2 (en) * | 2024-05-30 | 2025-12-04 | The Children's Medical Center Corporation | Compositions and methods for treating sepsis |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) * | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| CA2273288A1 (en) * | 1996-12-19 | 1998-06-25 | James Joseph Gibbons | Method of treating or inhibiting neutropenia |
| AU9084601A (en) | 2000-09-08 | 2002-03-22 | Massachusetts Inst Technology | G-csf analog compositions and methods |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| WO2004100972A1 (ja) | 2003-05-16 | 2004-11-25 | Kyowa Hakko Kogyo Co., Ltd. | 組織破壊を伴う疾患の予防及び／または治療剤 |
| EP1621191A1 (en) * | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| JP2008509928A (ja) * | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| RS51506B (sr) | 2004-12-02 | 2011-06-30 | Venus Remedies Limited H. O&R&D. | Smeše za suzbijanje beta-laktamazom posredovane rezistencije na antibiotike upotrebom inhibitora beta-laktamaze, korisne za injekcije |
| WO2006071451A2 (en) * | 2004-12-03 | 2006-07-06 | The Regents Of The University Of California | Compounds that prevent macrophage apoptosis and uses thereof |
| CN101472572B (zh) | 2006-05-16 | 2012-10-10 | Io治疗有限责任公司 | Rar拮抗剂或反向激动剂在治疗化学疗法和/或放射疗法副作用中的用途 |
| MX2009009997A (es) * | 2007-03-30 | 2009-12-08 | Tmrc Co Ltd | Preparacion de la capsula de tamibarotene. |
| JP2011505386A (ja) * | 2007-12-06 | 2011-02-24 | シーエスエル、リミテッド | 白血病性幹細胞の阻害方法 |
| US8580516B2 (en) | 2008-09-05 | 2013-11-12 | University Of Chicago | Methods and compositions for direct detection of DNA damage |
| AU2010309388B2 (en) | 2009-10-19 | 2016-03-10 | Laila Nutraceuticals | Extracts, fractions and compositions comprising acetogenins and their applications |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| EP2847198B1 (en) * | 2012-05-08 | 2016-12-14 | Lycera Corporation | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease |
| EP2858636B1 (en) | 2012-06-07 | 2018-09-05 | Childrens Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| DE102012011766B3 (de) | 2012-06-15 | 2013-12-19 | Voith Patent Gmbh | Getriebeeinheit |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
-
2013
- 2013-06-07 EP EP13800873.5A patent/EP2858636B1/en not_active Not-in-force
- 2013-06-07 CN CN201380041537.6A patent/CN104519879B/zh not_active Expired - Fee Related
- 2013-06-07 BR BR112014030279A patent/BR112014030279A2/pt not_active Application Discontinuation
- 2013-06-07 NZ NZ702415A patent/NZ702415A/en not_active IP Right Cessation
- 2013-06-07 WO PCT/US2013/044828 patent/WO2013185105A1/en not_active Ceased
- 2013-06-07 ES ES13800873.5T patent/ES2691493T3/es active Active
- 2013-06-07 MX MX2014014930A patent/MX365321B/es active IP Right Grant
- 2013-06-07 KR KR1020157000014A patent/KR102083046B1/ko not_active Expired - Fee Related
- 2013-06-07 RU RU2014153988A patent/RU2650962C2/ru not_active IP Right Cessation
- 2013-06-07 AU AU2013270674A patent/AU2013270674B2/en not_active Ceased
- 2013-06-07 US US14/405,141 patent/US11116738B2/en active Active
- 2013-06-07 CA CA2874850A patent/CA2874850A1/en not_active Abandoned
- 2013-06-07 JP JP2015516261A patent/JP6295249B2/ja not_active Expired - Fee Related